Advance Search
ZHANG Qiu, SUN Ling, WANG Qingjie, JI Yuan, JIANG Jianguang. Value of growth differentiation factor-15 in predicting risk of acute kidney injury in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 15-18. DOI: 10.7619/jcmp.202016004
Citation: ZHANG Qiu, SUN Ling, WANG Qingjie, JI Yuan, JIANG Jianguang. Value of growth differentiation factor-15 in predicting risk of acute kidney injury in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 15-18. DOI: 10.7619/jcmp.202016004
shu

Value of growth differentiation factor-15 in predicting risk of acute kidney injury in patients with acute coronary syndrome

  • Department of Cardiology, Changzhou City Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, Jiangsu, 213000

More Information
  • Received Date: May 18, 2020
  • Available Online: September 14, 2020
    Graphical Abstract
    • Abstract
  • Objective To evaluate the value of growth differentiation factor-15(GDF-15)in predicting risk of acute kidney injury(AKI)in patients with acute coronary syndrome(ACS). Methods Totally 694 ACS patients were enrolled as research objects. Venous blood of all patients were collected at the time of admission. The expression levels of GDF-15 were measured by enzyme-linked immunosorbent assay(ELISA). The patients were divided into experimental group(AKI group, n=81)and control group(non-AKI group, n=613)according occurrence of AKI. GDF-15 levels between the two groups were compared. Multivariate logistic regression analysis was performed to analyze correlation between GDF-15 level and AKI risk during hospitalization in ACS patients. The receiver operating characteristic(ROC)curve was used to evaluate the predictive value of GDF-15 in AKI risk. Results The occurrence of AKI in 694 patients was 11.67%. GDF-15 level at admission in the experimental group was higher than that in the control group ［(1 320.24±281.71)versus(979.88±319.77)ng/L, P<0.05］. High expression of GDF-15 was an independent risk factor of AKI in ACS patients during hospitalization(OR: 1.004, 95% confidence interval(CI): 1.003-1.005, P<0.001). The area under the curves(AUC)of plasma GDF-15 was 0.774, with 95% CI of 0.723 to 0.824. Conclusion High level of GDF-15 is an independent risk factor of AKI in ACS patients, which has a higher predictive value for AKI.
    • FullText(HTML)
    • References (19)
  • GUPTA R, GURM H S, BHATT D L, et al. Renal failure after percutaneous coronary intervention is associated with high mortality[J]. Catheter Cardiovasc Interv, 2005, 64(4): 442-448.
    KATSIKI N, ATHYROS V G, KARAGIANNIS A, et al. Contrast-induced nephropathy[J]. Angiology, 2015, 66(6): 508-513.
    LAMEIRE N, KELLUM J A, KDIGO AKI Guideline Work Group. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary(Part 2)[J]. Crit Care, 2013, 17(1): 205.
    GROSSMAN P M, ALI S S, ARONOW H D, et al. Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium[J]. J Interv Cardiol, 2017, 30(3): 274-280.
    MCCULLOUGH P A, ADAM A, BECKER C R, et al. Epidemiology and prognostic implications of contrast-induced nephropathy[J]. Am J Cardiol, 2006, 98(6A): 5K-13K.
    MCCULLOUGH P A, ADAM A, BECKER C R, et al. Risk prediction of contrast-induced nephropathy[J]. Am J Cardiol, 2006, 98(6A): 27K-36K.
    HERINGLAKE M, CHARITOS E I, ERBER K, et al. Preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery[J]. Crit Care, 2016, 20(1): 317.
    ZHANG W, CHU H C, XUE F. Assessing preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery[J]. Crit Care, 2017, 21(1): 53.
    NISHIO E, WATANABE Y. Transforming growth factor beta is a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for catalase activity and glutathione peroxidase activity[J]. Biochem Biophys Res Commun, 1997, 232(1): 1-4.
    WALLENTIN L, HIJAZI Z, ANDERSSON U, et al. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation(ARISTOTLE)trial[J]. Circulation, 2014, 130(21): 1847-1858.
    KEMPF T, EDEN M, STRELAU J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury[J]. Circ Res, 2006, 98(3): 351-360.
    SUN L, WANG Q. Mid-term prognostic value of serum growth differentiation factor-15 in patients with acute coronary syndrome[J]. Chinese Journal of Arteriosclerosis, 2017, 25: 505-508.
    HAGSTRÖM E, HELD C, STEWART R A, et al. Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease[J]. Clin Chem, 2017, 63(1): 325-333.
    EGGERS K M, KEMPF T, LAGERQVIST B, et al. Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome[J]. Circ Cardiovasc Genet, 2010, 3(1): 88-96.
    KEMPF T, BJÖRKLUND E, OLOFSSON S, et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction[J]. Eur Heart J, 2007, 28(23): 2858-2865.
    EGGERS K M, KEMPF T, WALLENTIN L, et al. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals[J]. Clin Chem, 2013, 59(7): 1091-1098.
    SUN L, ZANG X, SONG Y, et al. Relations between growth differentiation factor-15 and no-reflow in patients with acute myocardial infarction[J]. Chinese Journal of Arteriosclerosis, 2017, 26: 599-603.
    WOLLERT K C, KEMPF T, WALLENTIN L. Growth differentiation factor 15 as a biomarker in cardiovascular disease[J]. Clin Chem, 2017, 63(1): 140-151.
    KAHLI A, GUENANCIA C, ZELLER M, et al. Growth differentiation factor-15(GDF-15)levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass[J]. PLoS One, 2014, 9(8): e105759.
    • Related Articles

Catalog

    Get Citation
    PDF
    XML
    Article views (431) PDF downloads (7) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return